Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
Conditions
Interventions
Intervention1: Estrogen and progesterone receptors.: The specific nuclear receptor proteins for estrogen and progesterone are Estrogen Receptor (ER) and Progesterone Receptor (PR) which are present in
Sponsors
Rohilkhand Medical College Bareilly
Eligibility
Inclusion criteria
Inclusion criteria: All the endometrial biopsies and hysterectomy specimens in the age group of 18-55 years of reproductive and peri-menopausal age groups presenting with abnormal uterine bleeding received in the Pathology department during the study period would be included.
Exclusion criteria
Exclusion criteria: Inadequate samples Endometrial and hysterectomy biopsies of patients with clinical details other than AUB Cases of post-menopausal bleeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Study of immunohistochemical expression and grading of estrogen and progesterone receptors in the endometrial tissues in cases of abnormal uterine bleeding. Morphometric evaluation of blood vessels in cases of abnormal uterine bleeding. Timepoint: NIL | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of expression of estrogen and progesterone receptors and blood vessel morphometry in causes (PALM-COEIN) of abnormal uterine bleeding. Timepoint: NIL | — |
Countries
India
Contacts
Public ContactNeeti
Rohilkhand Medical College, Bareilly.
Outcome results
None listed